In vitro effect of homocysteine on nucleotide hydrolysis by blood serum from adult rats

Chemico-Biological Interactions

Volumn 160, Issue 2, 2006, Pages 159-164

  Böhmer, Ana Elisa ^a   Pochmann, Daniela ^a   Sarkis, João J F ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Blood serum; Cardiovascular disease; Homocysteine; Nucleotidases

Indexed keywords

ADENINE NUCLEOTIDE DERIVATIVE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; HOMOCYSTEINE;

AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME KINETICS; HYDROLYSIS; IC 50; MALE; NONHUMAN; RAT; SERUM;

5'-NUCLEOTIDASE; ADENINE NUCLEOTIDES; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HOMOCYSTEINE; HYDROLYSIS; INHIBITORY CONCENTRATION 50; MALE; PYROPHOSPHATASES; RATS; RATS, WISTAR;

ANIMALIA;

EID: 33644801333     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2006.01.004     Document Type: Article

References (52)

1. K.S. McCully Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis Am. J. Pathol. 56 1969 111 128
2. S.H. Mudd, H.L. Levy, and F. Skovby Disorders of transulfuration C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The Metabolic and Molecular Basis of Inherited Disease 8th ed. 2001 McGraw-Hill New York 1279 1327
3. M.R. Malinow Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis Circulation 81 1990 2004 2006
4. E.L. Mayer, D.W. Jacobsen, and K. Robinson Homocysteine and coronary atherosclerosis J. Am. Coll. Cardiol. 27 1996 517 527
5. C.J. Boushey, S.A. Beresford, G.S. Omenn, and A.G. Motulsky A quantitative assessment of plasma homocysteine as a risk factor for vascular disease JAMA 274 1995 1049 1057
6. P.J. Stubbs, M.K. Alobaidi, R.M. Conroy, B. Mus, P.O. Collinson, I.M. Path-Graham, and M.I. Frepi-Noble Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes Circulation 102 2000 605 610
7. M.P. Senaratne, J. Griffiths, and J. Nagendran Elevation of plasma homocysteine levels associated with acute myocardial infarction Clin. Invest. Med. 23 4 2000 220 226
8. D. Qujeq, T.S. Omran, and L. Hosini Correlation between total homocysteine, low-density lipoprotein cholesterol and high density lipoprotein cholesterol in the serum of patients with myocardial infarction Clin. Biochem. 34 2 2001 97 101
9. M.M. ElKossi, and M.M. Zakhhary Oxidative stress in the context of acute cerebrovascular stroke Stroke 31 8 2000 1889 1892
10. M. Markis Homocysteinemia and thrombosis Clin. Lab. Haematol. 22 3 2000 133 143
11. G.J. Hankey, and J.W. Eikelboom Homocysteine and vascular disease Lancet 354 1999 407 413
12. J.D. Symons, A.E. Mullick, J.L. Ensunsa, A.A. Ma, and J.C. Rutledge Hyperhomocysteinaemia evoked by folate depletion: effects on coronary and carotid arterial function Arterioscler. Thromb. Vasc. Biol. 22 2002 772 780
13. F.M. Faraci Hyperhomocysteinaemia: a million ways to lose control Arterioscler. Thromb. Vasc. Biol. 23 2003 371 373
14. F.M. Faraci, and S.R. Lentz Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction Stroke 35 2004 345 347
15. S.J. Su, L.W. Huang, L.S. Pai, H.W. Liu, and K.L. Chang Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression Nutrition 21 10 2005 994 1002
16. A.M. Gori, A.M. Corsi, S. Fedi, A. Gazzini, F. Sofi, B. Bartali, S. Bandinelli, G.F. Gensini, R. Abbate, and L.A. Ferrucci A proinflammatory state is associated with hyperhomocysteinemia in the elderly Am. J. Clin. Nutr. 82 2 2005 335 341
17. S. Dalal, S.M. Parkin, S. Homer-Vanniasinkam, and A. Nicolaou Effect of homocysteine on cytokine production by human endothelial cells and monocytes Ann. Clin. Biochem. 40 5 2003 534 541
18. R. Poddar, N. Sivasubramanian, P.M. Dibello, K. Robinson, and D. Jacobsen Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease Circulation 103 2001 2717 2723
19. G. Wang, K. O, Homocysteine stimulates the expression of monocyte chemoattractant protein-1 receptor (CCR2) in human monocytes: possible involvement of oxygen free radicals, Biochem. J. 357 (2001) 233-240.
20. G. Wang, Y.L. Siow, K. O, Homocysteine induces monocyte chemoattractant protein-1 expression by activating NF-kappa B in THP-1 macrophages, Am. J. Physiol. Heart Circ. Physiol. 280 (2001) 2840-2847.
21. Y.F. Chen, P.L. Li, and A.P. Zou Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function Circulation 106 10 2002 1275 1281
22. N.P. Riksen, G.A. Rongen, G.H.J. Boers, H.J. Blom, P.H.H. van den Broek, and P. Smits Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia Arterioscler Thromb. Vasc. Biol. 25 1 2005 109 114
23. H.J. Agteresch, P.C. Dagnelie, J.W. van den Berg, and J.L. Wilson Adenosine triphosphate: established and potential clinical applications Drugs 58 1999 211 232
24. S. Latini, and F. Pedata Adenosine in the central nervous system: release mechanisms and extracellular concentrations J. Neurochem. 2079 2001 463 484
25. V. Ravelic P2 receptors in the central and peripheral nervous systems moduling sympathetic vasomotor tone J. Auton. Nerv. Syst. 81 2000 205 211
26. G. Soslau, and D. Youngprapakorn A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation Biochim. Biophys. Acta 1355 1997 131 140
27. M. Pieber, M.A. Valenzuela, A.M. Kettlun, M. Mancilla, E. Aranda, L. Collados, and A. Traverso-Cori ATPase-ADPase activities of rat placental tissue Comp. Biochem. Physiol. 100B 1991 281 285
28. S.B. Coade, and J.D. Pearson Metabolism of adenine nucleotides in human blood Circ. Res. 65 1989 531 537
29. G.V.R. Born Aggregation of blood platelets by adenosine diphosphate and its reversal Nature (London) 194 1962 927 929
30. G.V.R. Born, and M.J. Cross The aggregation of blood platelets J. Physiol. 168 1963 178 195
31. H. Zimmermann Ectonucleotidases: some recent developments and a note on nomenclature Drug Dev. Res. 52 2001 44 56
32. O. Meyerhof The origin of the reaction of Harden and Young in cell-free alcoholic fermentation J. Biol. Chem. 157 1945 105 109
33. J.P. Oses, C.M. Cardoso, R.A. Germano, I.B. Kirst, B. Rücker, C.R. Fürstenau, M.R. Wink, C.D. Bonan, A.M.O. Battastini, and J.J.F. Sarkis Soluble NTPDase: an additional system of nucleotide hydrolysis in rat blood serum Life Sci. 74 26 2004 3275 3284
34. W. Chen, and G. Guidotti Soluble apyrases release ADP during ATP hydrolysis Biochem. Biophys. Res. Commun. 282 1 2001 90 95
35. 2+-ATPase activity Anal. Biochem. 157 1986 375 380
36. M.M. Bradford A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 218 254
37. M. Dixon, and E.C. Webb Enzymes 2nd ed. 1964 Longmans London and Colchester p. 950
38. P. Chen, R. Pooddar, E.V. Tipa, P.M. Dibello, C.D. Moravec, K. Robinson, R. Green, W.D. Kruger, T.A. Garrow, and D.W. Jacobsen Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease Adv. Enzyme Regul. 39 1999 93 109
39. G.R. Upchurch Jr., G.N. Welch, A.J. Fabian, A. Pigazzi, J.F. Keaney Jr., and J. Loscalzo Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase J. Biol. Chem. 272 1997 177 185
40. O. Stanger, W. Herrmann, K. Pietrzik, B. Fowler, J. Geisel, J. Dierkes, and M. Weger Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases Z. Kardiol. 93 2004 439 453
41. M. Den Heijer, F.R. Rosendaal, H.J. Blom, W.B. Gerrits, and G.M. Bos Hyperhomocysteinemia and venous thrombosis: a meta-analysis Thromb. Haemostasis 80 1998 874 877
42. Y.F. Chen, P.L. Li, and A.P. Zou Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function Circulation 106 2002 1275 1281
43. F.P. Gendron, O. Benrezzak, B.W. Krugh, Q. Kong, G.A. Weisman, and A.R. Beaudoin Purine signaling and potential new therapeutic approach: possible outcomes of NTPDase inhibition Curr. Drug Targets 3 Suppl. 3 2002 229 245
44. M. Imai, K. Takigami, O. Guckelberger, K. Enjyoji, R.N. Smith, Y. Lin, J. Sevigny, R.D. Rosenberg, F.H. Bach, and S.C. Robson Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1) cd39 in xenograft rejection Mol. Med. 5 1999 743 752
45. G. Burnstock Dual control of local blood flow by purines Ann. NY Acad. Sci. 603 1990 31 45
46. C. Gachet ADP receptors of platelets and their inhibition Thromb. Haemostasis 86 1 2001 222 232
47. C. Konishi, Y. Naito, and N. Ohara Age-related changes in adenosine 5′-triphosphate-induced constriction of isolated, perfused mesenteric arteries of rats Life Sci. 64 1999 1265 1273
48. R.N. Puri, and R.W. Colman ADP-induced platelet activation Crit. Rev. Biochem. Mol. Biol. 32 6 1997 437 502
49. V. Ralevic, and G. Burnstock Involvement of purinergic signaling in cardiovascular diseases Drug News Perspect. 16 3 2003 133 140
50. H. Refsum, P.M. Ueland, O. Nygard, and S.E. Vollset Homocysteine and cardiovascular disease Annu. Rev. Med. 49 1998 31 62
51. P.M. Ridker, J.E. Manson, J.E. Buring, J. Shih, M. Matias, and C.H. Hennekens Homocysteine and risk of cardiovascular disease among postmenopausal women JAMA 281 1999 1817 1821
52. K. Berg, M.R. Malinow, P. Kierulf, and B. Upson Population variation and genetics of plasma homocyst(e)ine level Clin. Genet. 41 1992 315 321